Product correctly added to cart.

discount label
Emixustat
View 3D

Biosynth logo

Emixustat

CAS: 1141777-14-1

Ref. 3D-FE171071

1mg
213.00 €
2mg
340.00 €
5mg
479.00 €
10mg
569.00 €
25mg
1,016.00 €
Estimated delivery in United States, on Friday 14 Jun 2024

Product Information

Name:
Emixustat
Synonyms:
  • (aR)-a-(2-Aminoethyl)-3-(cyclohexylmethoxy)benzenemethanol
Description:

Emixustat is a chemical inhibitor that inhibits the activity of the cation channel TRPM1. TRPM1 is expressed in choroidal neovascularization and proliferative diabetic retinopathy. It also has shown potential as a diagnostic agent for these eye disorders. Emixustat has been shown to inhibit the production of growth factors, which may be a cause for its therapeutic effect in both congenital amaurosis and growth factor-related eye disorders. Emixustat is an investigational drug that has not been approved by the FDA yet, but it is currently in phase III clinical trials.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
263.38 g/mol
Formula:
C16H25NO2
Purity:
Min. 95%
Color/Form:
Colourless To Yellow Liquid
InChI:
InChI=1S/C16H25NO2/c17-10-9-16(18)14-7-4-8-15(11-14)19-12-13-5-2-1-3-6-13/h4,7-8,11,13,16,18H,1-3,5-6,9-10,12,17H2/t16-/m1/s1
InChI key:
InChIKey=WJIGGYYSZBWCGC-MRXNPFEDSA-N
SMILES:
NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FE171071 Emixustat

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".